Can-Fite BioPharma (CANF) stock jumped 107% after namodenoson successfully completed Phase 2a safety testing in 20 pancreatic cancer patients.

Detailed price information for Can-Fite Biopharma Ltd ADR (CANF-A) from The Globe and Mail including charting and trades.

Association of time to second-line (2L) immune-checkpoint inhibitors (ICI) and outcomes with ICIs in patients (pts) with advanced urothelial carcinoma (aUC). This is an ASCO Meeting Abstract from the ...

The results include a comparison between two different basis functions for temporal selectivity and how these generate different predictions for the dynamics of neural populations. The conclusions are ...

Snopes rates rumors based on available evidence to help readers quickly ascertain their credibility. We always strive to be precise, accurate, fair and transparent with our choices. It’s important to ...

How much collagen you should take depends on your diet, age, health needs, and the form of the supplement, since there are no official daily guidelines. Research suggests that 2.5 to 15 grams of ...

The U.S. Environmental Protection Agency has issued new labels for use of over-the-top dicamba products in tolerant soybeans and cotton that include temperature-based application limits, as well as ac ...

RAMSEY, NJ / / February 25, 2026 / Konica Minolta Business Solutions U.S.A., Inc. ( Konica Minolta ) is proud to announce it has been positioned as a ...

New research shows overwhelmed customers are opting to throw away food when faced with confusing food safety labels. AddedJun 11th, 2025 Two wild weather systems are ...